What do you recommend for fertility preservation in pediatric patients with impending cyclophosphamide use for treatment of a rheumatic disease?
Answer from: at Academic Institution
Cyclophosphamide (CYC) is an alkylating agent primarily used in the treatment of malignant lymphomas, and its gonadotoxic properties are well-established. CYC can cause ovarian toxicity via follicle atresia and granulosa cell apoptosis in females as well as oligospermia and azoospermia in males. In ...
Comments
at Uniformed Services University of the Health Sciences (USUHS) @Deirdre De Ranieri: I am so glad this Q and A pop...
at Uniformed Services University of the Health Sciences (USUHS) Thanks for your comments, @Cuoghi Edens. I wish oo...
I am not a pediatric rheumatologist so I would need to defer to a pediatric rheumatologist regarding this question. However, the Euro lupus protocol 500mg q two weeks x 6, has not been shown to significantly reduce fertility. Moreover, impairment of ovarian function after cyclophosphamide therapy is...
Comments
at University of California (San Francisco) School of Medicine Is there a concern for the potential of future con...
@Deirdre De Ranieri: I am so glad this Q and A pop...
Thanks for your comments, @Cuoghi Edens. I wish oo...